A study shows that the mutant virus is more easily transmitted and grows better within hosts, likely aiding its dominance. The mutation, researchers say, should not interfere with the effectiveness of vaccines against the virus.
Neither of the new viruses is known to infect people, but the findings reinforce the important work scientists are undertaking to study the effects of a changing environment on human and animal diseases.
UW neuroscientists led by Su-Chun Zhang found that neurons derived from stem cells can connect with native neurons and restore motor functions. But more research is needed to translate the findings from mice to people.
Researchers believe the same approach can be applied to several other respiratory pathogens, including the novel coronavirus that causes COVID-19.
UW–Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination — including a COVID-19 vaccine that has advanced to clinical trials.
The animals are useful to researchers trying to understand SARS-CoV-2 and in the evaluation of vaccines, treatments and drugs against the disease it causes.
Researchers advise that people with symptoms avoid contact with cats, and cat owners should keep their pets indoors to limit contact with other people and animals.
Researchers hope to better understand how coronaviruses enter cells, spread, and cause varying immune responses in different individuals.
Work by Brian Parks and collaborators provides a new target for understanding the genetic risk of high cholesterol, which is linked to heart disease.
Refinement of the CoroFlu vaccine concept and testing in laboratory animal models at UW–Madison is expected to take three to six months. CoroFlu could be in human clinical trials by fall, 2020.